# OnCo record paper-olympiad-nejm-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-olympiad-nejm-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-olympiad-nejm-2017" ;
  schema:name "OlympiAD: olaparib versus chemotherapy in metastatic breast cancer with a germline BRCA mutation"@en ;
  schema:description "In women with metastatic HER2-negative breast cancer and an inherited BRCA mutation, the PARP inhibitor tablet olaparib delayed progression by almost three months compared with chemotherapy and caused fewer severe side effects."@en ;
  schema:url <https://onco.cc/key-papers/paper-olympiad-nejm-2017/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1706450>, <https://pubmed.ncbi.nlm.nih.gov/28578601/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1706450> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Robson M, Im SA, Senkus E, et al." ;
  onco:cancers <https://onco.cc/cancers/tnbc-metastatic/> ;
  onco:drugs <https://onco.cc/drugs/olaparib/> ;
  onco:trials <https://onco.cc/trials/olympiad/> ;
  onco:journals <https://onco.cc/journals/nejm/> .